F4-PHARMA GES M B H -  

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 9.994.978 2.622.750 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACCELOPMENT SCHWEIZ1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
AZIENDA SOCIOSANITARIA TERRITORIALE FATEBENEFRATELLI SACCO1
CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE1
EUROPEAN SOCIETY OF ANAESTHESIOLOGY AND INTENSIVE CARE AISBL1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
INSTITUT CATALA DE LA SALUT1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS1
MEDICAL INTELLIGENT DATA ANALYTICS1
UNIVERSITA DEGLI STUDI DI PERUGIA1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITATEA DE MEDICINA SI FARMACIE CAROL DAVILA DIN BUCURESTI1
UNIVERSITY COLLEGE DUBLIN1
UNIVERSITY OF TAMPERE1

Constancy:

Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-08-01Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19 COVendparticipant9.994.97818